Produced by Sanofi-Aventis, Taxotere is a chemotherapy drug. In fact, it is one of the most often prescribed chemotherapy drugs in its class, earning Sanofi more than $3 billion in just one year. Many doctors use Taxotere in the treatment of their breast-cancer patients.
Unfortunately, this drug has been linked to side effects that permanently impact the lives of many women.
To date, approximately nine percent of breast cancer patients have sustained prolonged or permanent hair loss, also known as alopecia. This irreversible effect has a considerable impact on many women who report experiencing depression, distress, and anxiety after losing their hair.